Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
According to the post-hoc analysis of SURPASS-3 (NCT03882970), 52 weeks of tirzepatide treatment resulted in a 4.4% reduction in MFI in individuals with T2DM [85]
Quality sourcing and clinician oversight matter
PlexusDx Precision Peptide Genetic Test ($298) analyzes peptide-pathway variants including MC4R that influence appetite regulation and metabolic response
Whether it be Las Vegas, Henderson, Reno, or Enterprise businesses and patients living in Nevada can receive our products in the shortest turnaround times
US$ 26.87
US$ 27.44
US$ 22.54
US$ 22.61
US$ 29.18
US$ 26.14
US$ 23.26
